** Shares of ECS Botanics Holdings ECS.AX rise as much as
21.7% to A$0.028, their highest since Feb 6
** Medicinal cannabis co says its Q4 revenue more than
doubled to A$4.97 mln ($3.32 mln), from last year
** Co says it saw a 51.5% increase in production of dried
cannabis flower in 2022/2023 season
** Co enters FY24 off the back of two major supply
agreements and well positioned to continue to grow revenue and
profit
** Stock up 15% YTD, as of last close
($1 = 1.4959 Australian dollars)
(Reporting by Ayushman Ojha in Bengaluru)
((Ayushman.ojha@thomsonreuters.com;))